<DOC>
	<DOCNO>NCT01082640</DOCNO>
	<brief_summary>The purpose study determine effect febuxostat , daily ( QD ) twice daily ( BID ) , renal function gout patient elevate serum urate level moderate severe renal impairment .</brief_summary>
	<brief_title>Effect Febuxostat Renal Function Patients With Gout Moderate Severe Renal Impairment</brief_title>
	<detailed_description>Gout cause high level uric acid body , associate broad range condition include heart disease , chronic kidney disease high blood pressure . Hyperuricemia , define elevation serum urate level , develop gout urate crystal form body settle joint organ . Approximately 40-60 % patient hyperuricemia gout degree renal impairment . Hyperuricemia long associate renal disease , chronic hyperuricemia see gout lead deposition urate crystal result diminished renal function . This study evaluate effect febuxostat renal function patient hyperuricemia gout moderate severe renal impairment . All participant must average sit blood pressure measurement le 160 mmHg systolic le 95 mmHg diastolic . All participant must meet American Rheumatism Association ( ARA ) diagnostic criterion gout ( subject tophi exclude ) . Participants expect return site approximately 10 visit .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Hyperuricemia</mesh_term>
	<mesh_term>Febuxostat</mesh_term>
	<criteria>Must serum urate great 7 mg/dL serum creatinine great equal 1.5 mg Day 21 Must history presence gout define one American Rheumatism Association criterion diagnosis gout ( criterion relate tophus exclude purpose study ) Must estimate Glomerular Filtration Rate ( eGFR ) 15 great , less equal 50 mL/min , AND serum creatinine great 1.5 mg/dL Screening Visit Day 21 Has secondary hyperuricemia ( eg , due myeloproliferative disorder , organ transplant ) Has tophaceous gout Has history xanthinuria Has receive aspirin great 325 mg/day within 35 day prior Day 1/Randomization Visit Has know hypersensitivity allergy allopurinol component formulation Has know hypersensitivity febuxostat colchicine component formulation Has myocardial infarction stroke within 90 day prior Screening Visit Has alanine aminotransferase and/or aspartate aminotransferase value great 2.0 time upper limit normal Has end stage renal disease likely candidate dialysis 1 year study period Has serum creatinine less equal 1.5 mg/dL , estimate Glomerular Filtration Rate Day 21 Screening Visit less 15 mL/min great 50 mL/min calculate central laboratory Is require take exclude medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Gout</keyword>
	<keyword>physiology</keyword>
	<keyword>Hyperuricemia</keyword>
	<keyword>Uric Acid</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>